The Internationale Pharmaceutica Sciencia (IPS) is an international peer review quarterly, scientific and professional journal emphasizing quality pharmaceutical discoveries and innovations. The Internationale Pharmaceutica Sciencia (IPS) provides a medium for publication of novel and innovative research from the areas of Pharmaceutical Sciences & Technology. The Internationale Pharmaceutica Sciencia (IPS) publishes full length research reports, review articles,and scientific commentaries & communication on all aspects of the pharmaceutical sciences with strong sciences with strong emphasis on novelty, originality and scientific quality. The Editors welcome articles in this multidisciplinary field, ranging from Drug Development to Drug Discovery. More specifically, the Journal publishes reports in medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery systems including gene delivery, drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation.
The journal is currently accepting articles for its volume 10. Volume 1-9 is archived under the archival policy of previous publisher.
All Published Work is Licensed under a creative commons attribution 4.0 international license.This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. International Journal of Pharmaceutics & Pharmacology supports the Open Access initiative. We believe in giving the maximum exposure to our published articles, so that the author could get the highest impact for his publications.
International Journal of Pharmaceutics & Pharmacology discourages plagiarism. All the manuscripts submitted to the journal undergo strict plagiarism checking using quality plagiarism checker. Currently we are doing it through Turnitin. Plagiarism in manuscript beyong 20% is liable to be rejected and considered not fit for further processing of the article. We have an in house team of reviewers who performs the preliminary reviewing of the manuscript. If the articles get accepted, it is forwarded to the subject specialist for his comments. All the submitted manuscript is assigned an Editor from our Editorial Board Members. The decision of the Editor (Accept/Revise/Reject) for respective article is deemed to be final and will not be revoked in any circumstances.